Prostate cancer

James Mohler, Richard J. Babaian, Robert R. Bahnson, Barry Boston, Anthony D'Amico, James A. Eastham, Ralph J. Hauke, Robert P. Huben, Philip Kantoff, Mark Kawachi, Michael Kuettel, Paul H. Lange, Chris Logothetis, Gary MacVicar, Alan Pollack, Julio M. Pow-Sang, Mack Roach, Howard Sandler, Dennis Shrieve, Sandhya SrinivasPrzemyslaw Twardowski, Donald A. Urban, Patrick C. Walsh

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


The intention of the NCCN Prostate Cancer Guidelines is to provide a framework on which to base treatment decisions. Prostate cancer is a complex disease, with many controversial aspects of management and with a dearth of sound data to support treatment recommendations. Several variables (including life expectancy, disease characteristics, predicted outcomes, and patient preferences) must be considered by the patient and physician in tailoring prostate cancer therapy to the individual patient.

Original languageEnglish (US)
Pages (from-to)650-683
Number of pages34
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number7
StatePublished - Aug 2007
Externally publishedYes


  • Biopsy active surveillance
  • Carcinoma screening
  • Early detection
  • Life expectancy estimation
  • NCCN Clinical Practice Guidelines
  • Prostate cancer
  • Prostate-specific antigen
  • Robot-assisted laparoscopic radical prostatectomy

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Prostate cancer'. Together they form a unique fingerprint.

Cite this